March 10 (Reuters) - Valeant Pharmaceuticals International Inc (NYSE:VRX) VRX.TO
* Valeant - priced its previously announced offering of $1.25 billion aggregate principal amount of 6.50% senior secured notes due 2022
* Valeant - priced its previously announced offering of $2 billion aggregate principal amount of 7.00% senior secured notes due 2024
* Valeant announces pricing and upsize of private offering of senior secured notes
* Valeant - aggregate size of offering reflects an increase of $750 million from previously announced offering size
* Valeant -anticipates will pay down $350 million of revolving credit facility borrowings under credit facilities with proceeds of offering, cash on hand Source text for Eikon: ID:nPn3yMWjNa Further company coverage: VRX.TO